Investor profile
Jeito Capital has backed 10 European tech companies across 12 funding rounds between 2020 and 2025, joining rounds totalling €912M. Most active in Healthtech. Data as of 6 Aug 2026.
Hover a node for shared-deal counts; click a co-investor to open its profile.
Best viewed on a larger screen.
| Company | Country | Rounds | Total € |
|---|---|---|---|
| Quell Therapeutics | UK | 1 | €138M |
| Noema Pharma | Switzerland | 2 | €134M |
| Azafaros | Netherlands | 1 | €132M |
| EyeBiotech | UK | 2 | €118M |
| Neogene Therapeutics | Netherlands |
| Company | Stage | Amount | Date |
|---|---|---|---|
| Quell Therapeutics | Series B | €138M | 2021-11 |
| Azafaros | Series B | €132M | 2025-05 |
| Noema Pharma | Series B | €105M | 2023-03 |
| Neogene Therapeutics |
| 1 |
| €93M |
| Precirix | Belgium | 1 | €80M |
| Sparingvision | France | 1 | €75M |
| ReproNovo | Switzerland | 1 | €57M |
| CatalYm | Germany | 1 | €50M |
| NMD Pharma | Denmark | 1 | €35M |
| Other |
| €93M |
| 2020-09 |
| Precirix | Series B | €80M | 2022-03 |
| Sparingvision | Series B | €75M | 2022-09 |
| EyeBiotech | Series A | €61M | 2023-11 |
| EyeBiotech | Series A | €57M | 2022-02 |
| ReproNovo | Series A | €57M | 2025-05 |
| CatalYm | Series C | €50M | 2022-11 |
